Your session is about to expire
← Back to Search
Intensive Glucose Intervention for High Blood Sugar (PEGASUS Trial)
PEGASUS Trial Summary
This trial will look at whether closely monitoring and managing glucose levels in people with pancreatic cancer is possible and how it affects the cancer. Around 50 participants with pancreatic cancer will use continuous glucose monitors (CG
PEGASUS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowPEGASUS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.PEGASUS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are individuals currently able to participate in this study as active participants?
"According to details on clinicaltrials.gov, this study is presently in the recruitment phase. The trial was initially listed on 2/1/2024 and last revised on 2/8/2024."
How large is the patient population participating in this medical study?
"Indeed, the details on clinicaltrials.gov specify that this clinical investigation is actively seeking suitable candidates. The trial's initial posting was on February 1st, 2024, with the latest update made on February 8th, 2024. Recruitment aims to enroll a total of fifty patients from one designated site."
Share this study with friends
Copy Link
Messenger